Hospital
Sutter Bay Hospitals
Sutter Bay Hospitals was paid $35.23M by Medicaid between Jan 2018 and Nov 2024, across 223 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoSUTTER BAY HOSPITALS
SANTA ROSA, CA 95403
SANTA ROSA, CA 95403
33aNPI1740413798assigned 08/25/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$35.23M
24GClaims612,083
24DCodes billed223
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#83 of 410
Median peer was paid$6.90M
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GATES, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 76,247 | $3.82M | |
| 2019 | 83,983 | $3.90M | |
| 2020 | 78,971 | $4.10M | |
| 2021 | 96,844 | $5.96M | |
| 2022 | 109,557 | $6.54M | |
| 2023 | 87,385 | $5.40M | |
| 2024incomplete | 79,096 | $5.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 55,117 | 46,414 | $5.61M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 16% | 40,121 | 34,548 | $5.60M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8.2% | 5,478 | 5,231 | $2.90M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.0% | 10,618 | 7,984 | $1.77M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.1% | 11,486 | 10,039 | $1.44M |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 3,934 | 3,812 | $1.14M |
| 99201 | 2.9% | 8,000 | 6,257 | $1.03M | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.9% | 10,874 | 9,152 | $1.03M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.7% | 5,862 | 4,956 | $944K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 15,091 | 13,609 | $900K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.9% | 1,332 | 1,296 | $674K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.5% | 3,851 | 3,527 | $541K |
211 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 6,586 | $456K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 5,529 | $416K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 1,329 | $415K |
| 70498 | 1.2% | 786 | $406K | |
| 70496 | 1.1% | 748 | $382K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 6,157 | $376K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.1% | 778 | $370K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.0% | 1,407 | $369K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 6,807 | $347K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,631 | $342K |
| 80053 | Comprehensive metabolic panel | <1% | 33,523 | $304K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,991 | $295K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 496 | $265K |
| 71045 | Radiologic examination, chest; single view | <1% | 10,272 | $260K |
| 76830 | Ultrasound, transvaginal | <1% | 1,620 | $242K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 37,390 | $239K |
| J3490 | Unclassified drugs | <1% | 46,532 | $238K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,804 | $223K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,328 | $216K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,527 | $213K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,317 | $212K |
| 93971 | <1% | 818 | $209K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,430 | $199K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 308 | $190K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,325 | $184K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 275 | $169K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,635 | $150K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,720 | $135K |
| 59025 | Fetal non-stress test | <1% | 2,642 | $134K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 191 | $122K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 6,605 | $112K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12,780 | $109K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 11,293 | $100K |
| 82077 | <1% | 3,577 | $99K | |
| 84484 | <1% | 10,899 | $91K | |
| 97803 | <1% | 1,670 | $89K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 811 | $88K |
| 76770 | <1% | 483 | $81K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 564 | $79K |
| 76801 | <1% | 627 | $79K | |
| 96367 | <1% | 810 | $78K | |
| 83690 | <1% | 13,170 | $76K | |
| 73610 | <1% | 1,257 | $75K | |
| 73030 | <1% | 1,230 | $75K | |
| 83880 | <1% | 2,569 | $73K | |
| 73630 | <1% | 1,294 | $72K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 463 | $72K |
| 73130 | <1% | 1,210 | $71K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 10,634 | $70K |
| 80143 | <1% | 1,881 | $63K | |
| 0450 | Emergency room services | <1% | 1,025 | $62K |
| Z7502 | <1% | 1,623 | $62K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 469 | $62K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 543 | $61K |
| 87040 | <1% | 5,700 | $59K | |
| 80179 | <1% | 1,858 | $57K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,144 | $54K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,551 | $53K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,658 | $52K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,556 | $49K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,555 | $48K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 7,354 | $48K |
| 73110 | <1% | 730 | $44K | |
| 83605 | <1% | 4,755 | $44K | |
| 81003 | <1% | 19,360 | $43K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,939 | $41K |
| J2704 | Injection, propofol, 10 mg | <1% | 4,313 | $39K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 931 | $38K |
| 73564 | <1% | 651 | $38K | |
| 90715 | <1% | 788 | $34K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,434 | $33K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,340 | $32K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,362 | $31K |
| 72141 | <1% | 53 | $29K | |
| 73562 | <1% | 433 | $27K | |
| 71250 | <1% | 59 | $26K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,745 | $25K |
| 85379 | <1% | 2,606 | $22K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 3,539 | $22K |
| 85730 | <1% | 3,915 | $21K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,647 | $21K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,271 | $20K |
| 83735 | <1% | 3,519 | $19K | |
| 87634 | <1% | 327 | $19K | |
| 81025 | <1% | 5,577 | $19K | |
| 85610 | <1% | 5,285 | $18K | |
| 70486 | <1% | 38 | $18K | |
| 73221 | <1% | 28 | $17K | |
| 96523 | <1% | 127 | $17K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 13 | $17K |
| 87186 | <1% | 1,816 | $17K | |
| 87077 | <1% | 1,864 | $16K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,610 | $16K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,467 | $15K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,498 | $15K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,221 | $14K |
| 59425 | <1% | 92 | $14K | |
| 87400 | <1% | 1,766 | $14K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,542 | $13K |
| 97802 | <1% | 159 | $13K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,284 | $13K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 2,257 | $12K |
| 82805 | <1% | 530 | $12K | |
| 74018 | <1% | 289 | $11K | |
| 96402 | <1% | 275 | $10K | |
| 86900 | <1% | 3,468 | $10K | |
| 87430 | <1% | 923 | $9K | |
| 87149 | <1% | 77 | $9K | |
| 86901 | <1% | 3,173 | $9K | |
| 76870 | <1% | 67 | $9K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 543 | $8K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 53 | $8K |
| Z9725 | <1% | 194 | $8K | |
| 87081 | <1% | 976 | $8K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 724 | $8K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 61 | $8K |
| 82947 | <1% | 1,613 | $8K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 13 | $8K |
| 87631 | <1% | 46 | $7K | |
| 70491 | <1% | 13 | $7K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,040 | $7K |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 519 | $7K |
| 97750 | <1% | 52 | $6K | |
| 86850 | <1% | 2,183 | $6K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 108 | $6K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 561 | $5K |
| 86140 | <1% | 1,320 | $5K | |
| 87420 | <1% | 1,539 | $5K | |
| J1815 | Injection, insulin, per 5 units | <1% | 420 | $5K |
| 96415 | <1% | 46 | $4K | |
| 73502 | <1% | 62 | $4K | |
| 84145 | <1% | 223 | $4K | |
| 81001 | <1% | 1,128 | $4K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 196 | $4K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 25 | $4K |
| 72100 | <1% | 37 | $3K | |
| 72110 | <1% | 25 | $3K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 414 | $3K |
| 84702 | <1% | 243 | $3K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 29 | $3K |
| 73140 | <1% | 71 | $3K | |
| 82247 | <1% | 786 | $3K | |
| 94729 | <1% | 25 | $3K | |
| 72050 | <1% | 25 | $3K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 140 | $3K |
| 85652 | <1% | 1,265 | $3K | |
| 94726 | <1% | 25 | $2K | |
| 88342 | <1% | 164 | $2K | |
| S0028 | Injection, famotidine, 20 mg | <1% | 422 | $2K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 13 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 339 | $2K |
| 99199 | Unlisted special service, procedure or report | <1% | 26 | $2K |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 100 | $2K |
| 87210 | <1% | 576 | $2K | |
| 73080 | <1% | 28 | $2K | |
| 83789 | <1% | 36 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 28 | $2K |
| 51701 | <1% | 39 | $2K | |
| 12001 | <1% | 37 | $1K | |
| 82550 | <1% | 220 | $1K | |
| 84075 | <1% | 374 | $1K | |
| 84450 | <1% | 370 | $1K | |
| 82040 | <1% | 373 | $1K | |
| 94060 | <1% | 13 | $1K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 12 | $1K |
| 99070 | <1% | 77 | $1K | |
| 85027 | <1% | 209 | $1K | |
| 84155 | <1% | 370 | $921.57 | |
| 84703 | <1% | 157 | $882.34 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 58 | $864.67 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 89 | $861.76 |
| 96368 | <1% | 18 | $839.63 | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 33 | $806.36 |
| 73090 | <1% | 13 | $694.54 | |
| 29125 | <1% | 44 | $669.71 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 235 | $643.88 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 59 | $643.53 |
| 12011 | <1% | 12 | $593.19 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 43 | $557.28 |
| 10060 | <1% | 13 | $479.85 | |
| 84439 | <1% | 76 | $469.31 | |
| 88304 | <1% | 40 | $456.43 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 28 | $456.22 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 76 | $382.49 |
| 84132 | <1% | 111 | $343.75 | |
| 87088 | <1% | 37 | $327.32 | |
| 82248 | <1% | 84 | $291.40 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 37 | $290.19 |
| Z7610 | <1% | 25 | $260.36 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 46 | $259.23 |
| 80178 | <1% | 53 | $249.26 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 30 | $242.16 |
| 87205 | <1% | 71 | $238.10 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 22 | $193.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | <1% | 34 | $168.97 |
| 87045 | <1% | 17 | $158.08 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 17 | $157.46 |
| 86592 | <1% | 32 | $111.93 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $111.50 |
| 82570 | <1% | 33 | $108.14 | |
| 84295 | <1% | 39 | $98.35 | |
| 86308 | <1% | 27 | $96.93 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 508 | $91.09 |
| 87070 | <1% | 14 | $89.57 | |
| 87046 | <1% | 34 | $83.52 | |
| 87147 | <1% | 20 | $78.20 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 169 | $61.60 |
| 84156 | <1% | 21 | $50.76 | |
| 87899 | <1% | 13 | $50.70 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 281 | $25.01 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 27 | $12.34 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATES, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Sutter Bay Hospitals | Castro Valley, CA | $52.65M |
| Sutter Bay Hospitals | Oakland, CA | $46.80M |
| Sutter Bay Hospitals | Berkeley, CA | $43.78M |
| Sutter Bay Hospitals | Lakeport, CA | $39.50M |
| Sutter Bay Hospitals | Antioch, CA | $29.48M |
| Sutter Bay Hospitals | San Francisco, CA | $19.99M |
| Sutter Bay Hospitals | Burlingame, CA | $17.15M |
| Sutter Bay Hospitals | San Francisco, CA | $14.94M |
| Sutter Bay Hospitals | Novato, CA | $11.12M |
| Sutter Bay Hospitals | San Francisco, CA | $6.79M |
| Sutter Bay Hospitals | Lakeport, CA | $3.99M |
| Sutter East Bay Hospitals | Antioch, CA | $3.45M |
| Sutter Bay Hospitals | Burlingame, CA | $1.98M |
| Sutter Bay Hospitals | Lakeport, CA | $1.72M |
| Sutter East Bay Hospitals | Oakland, CA | $1.10M |
| Sutter Bay Hospitals | San Francisco, CA | $1.08M |
| Sutter East Bay Hospitals | Berkeley, CA | $946K |
| Sutter West Bay Hospitals | San Francisco, CA | $186K |
| Magnetic Imaging Affiliates, LLC | Oakland, CA | $112K |
| Sutter Bay Hospitals | Berkeley, CA | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.